Skip to content
OpenCapital
Get started

Adial Pharmaceuticals ADIL Q4 2024 Annual earnings

Reported March 4, 2025 · Before market open

EPS-$0.15Beat by $0.23
EPS estimate-$0.38

Next report

Aug 12, 2026 (In 1 week)
EPS estimate-$1.02

Versus estimates

Diluted EPS

Q1 2026-$1.48Beat by $1.25Q4 2025-$1.81Beat by $0.29Q3 2025-$2.00Beat by $0.25Q2 2025-$0.18Beat by $0.04Q1 2025-$0.34Beat by $0.16
Q4 2024-$0.15Beat by $0.23

Ask the moment Adial Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Adial Pharmaceuticals report Q4 2024 earnings?
Adial Pharmaceuticals (ADIL) reported Q4 2024 earnings on March 4, 2025 before market open.
What were Adial Pharmaceuticals's Q4 2024 revenue and EPS?
Adial Pharmaceuticals reported eps of $-0.15 for Q4 2024.
Did Adial Pharmaceuticals beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.38 by $0.23.
Where can I find Adial Pharmaceuticals's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001213900-25-019771) directly on SEC EDGAR. The filing index links above go to sec.gov.